Literature DB >> 10856001

Chronic-treated HIV: a neurologic disease.

J Booss1.   

Abstract

The concept of slow virus diseases was developed by Sigurdsson in the 1950s in studies of infections of Icelandic sheep, including Visna, a slow (lenti) viral infection of the central nervous system. Human immunodeficiency virus (HIV) belongs to the same lentivirus subfamily of retroviruses and causes significant dysfunction of all levels of the nervous system. Highly active antiretroviral therapy should allow host control of opportunistic infections, producing a clinical state of chronic-treated HIV. However, viral persistence may occur in the sanctuary of the central nervous system. As a consequence, major disabilities in the chronic-treated phase of the HIV epidemic may include cognitive impairment, gait disorders, and various pain syndromes. Policy planning will need to take into account the long-term residential, social, and health care needs of this population.

Entities:  

Mesh:

Year:  2000        PMID: 10856001      PMCID: PMC3456128          DOI: 10.1007/BF02390531

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  11 in total

1.  Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.

Authors:  G J Dore; P K Correll; Y Li; J M Kaldor; D A Cooper; B J Brew
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

2.  The AIDS epidemic--considerations for the 21st century.

Authors:  A S Fauci
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

3.  Exploring the benefits and limits of highly active antiretroviral therapy.

Authors:  R D'Aquila; B Walker
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

4.  The AIDS dementia complex: I. Clinical features.

Authors:  B A Navia; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

5.  HTLV-III infection in brains of children and adults with AIDS encephalopathy.

Authors:  G M Shaw; M E Harper; B H Hahn; L G Epstein; D C Gajdusek; R W Price; B A Navia; C K Petito; C J O'Hara; J E Groopman
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

6.  The AIDS dementia complex: II. Neuropathology.

Authors:  B A Navia; E S Cho; C K Petito; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

7.  Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome.

Authors:  C K Petito; B A Navia; E S Cho; B D Jordan; D C George; R W Price
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

8.  Screening for distal sensory peripheral neuropathy in HIV-infected persons in research and clinical settings.

Authors:  C M Marra; P Boutin; A C Collier
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

9.  Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients.

Authors:  W D Snider; D M Simpson; S Nielsen; J W Gold; C E Metroka; J B Posner
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

10.  A phase I/II trial of nimodipine for HIV-related neurologic complications.

Authors:  B A Navia; U Dafni; D Simpson; T Tucker; E Singer; J C McArthur; C Yiannoutsos; L Zaborski; S A Lipton
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

View more
  2 in total

1.  Undertreatment of pain in HIV+ adults in Thailand.

Authors:  Nathaniel M Robbins; Kanokporn Chaiklang; Khuanchai Supparatpinyo
Journal:  J Pain Symptom Manage       Date:  2012-09-29       Impact factor: 3.612

2.  Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus.

Authors:  Nathaniel M Robbins; Kanokporn Chaiklang; Khuanchai Supparatpinyo
Journal:  Antiinfect Agents       Date:  2016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.